Pet Technology A Paradigm Shift in Oncology: Phase 3 Trial Reveals Personalized mRNA Vaccine Cuts Melanoma Recurrence and Death Risk by 42 Percent October 25, 2026 Sagoh By Global Health and Science Correspondent In what leading oncologists are hailing as a "transformative" milestone in personalized medicine, pharmaceutical giants Merck and Moderna have released landmark Phase 3 clinical…
